Micro-cap gene therapy biotech Genprex sets IPO price at $5.00 – Nasdaq

Micro-cap gene therapy biotech Genprex sets IPO price at $5.00NasdaqGenprex, which is developing gene therapies for cancer, set the price for its upcoming IPO at $5.00. The company plans to offer a minimum of 2.0 million shares and a maximum of 4.5 million shares. At the midpoint, Genprex would raise $17.5 million at a … […]

from WordPress http://ift.tt/2l21g9N
via IFTTT

Newer Post Older Post